AI
Thursday, July 08, 2004 4:30:28 PM
Putting aside squalamine potential 5 years out, just wondering where the eyet data is so much better? Would appreciate any pointer.
P.S. You should have seen the recent leh comments on vegf-trap. "...VEGF-TRAP appeared thus far to be one of the
less promising emerging molecularly targeted drugs at ASCO."
Ouch
P.S. You should have seen the recent leh comments on vegf-trap. "...VEGF-TRAP appeared thus far to be one of the
less promising emerging molecularly targeted drugs at ASCO."
Ouch
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
